Sarah M. Anand

Sarah M. Anand

Hematology | Oncology
1540 E Hospital Dr
Floor 7 Reception B
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 12, 2025

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome.

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Journal: Blood advances
Published: October 29, 2024

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.

Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.

Journal: Frontiers in immunology
Published: March 18, 2024

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.

Journal: Journal of the American Heart Association
Published: December 29, 2023

Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.

Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.

Journal: Blood advances
Published: April 03, 2023

Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation.

Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation.

Journal: Nature medicine
Published: March 30, 2023

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.

Journal: Blood
Published: February 27, 2023

Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors.

Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors.

Journal: JACC. CardioOncology
Published: February 08, 2023

A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.

A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.

Journal: Transfusion
Published: November 18, 2022

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.

Journal: Transplantation and cellular therapy
Published: September 10, 2022

Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients.

Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients.

Journal: Bone marrow transplantation
Published: March 14, 2022

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation.

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation.

Journal: Blood advances
Published: April 05, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026